Results 41 to 50 of about 1,191,146 (396)

The type I interferon response in COVID-19: implications for treatment

open access: yesNature reviews. Immunology, 2020
Despite early reports to the contrary, there is increasing evidence that patients with severe COVID-19 have a robust type I interferon response, which contrasts with the delayed, possibly suppressed, interferon response seen early in infection.
Jeong Seok Lee, E. Shin
semanticscholar   +1 more source

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis [PDF]

open access: yes, 2003
OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness.
Abrams, K.   +6 more
core   +2 more sources

The IFITMs Inhibit Zika Virus Replication

open access: yesCell Reports, 2016
Zika virus has emerged as a severe health threat with a rapidly expanding range. The IFITM family of restriction factors inhibits the replication of a broad range of viruses, including the closely related flaviruses West Nile virus and dengue virus. Here,
George Savidis   +6 more
doaj   +1 more source

Double-edged effects of interferons on the regulation of cancer-immunity cycle

open access: yesOncoImmunology, 2021
Interferons (IFNs) are a large family of pleiotropic cytokines that regulate both innate and adaptive immunity and show anti-cancer effects in various cancer types.
Xiao Zhang   +7 more
doaj   +1 more source

Activation of cytosolic RNA sensors by endogenous ligands: roles in disease pathogenesis

open access: yesFrontiers in Immunology, 2023
Early detection of infection is a central and critical component of our innate immune system. Mammalian cells have developed specialized receptors that detect RNA with unusual structures or of foreign origin – a hallmark of many virus infections ...
Sarah Straub   +3 more
doaj   +1 more source

Interferon-α2b Treatment for COVID-19

open access: yesFrontiers in Immunology, 2020
The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon (IFN)-α2b in a cohort of confirmed COVID-19 cases in Wuhan, China. In
Qiong Zhou   +9 more
semanticscholar   +1 more source

Porcine innate and adaptative immune responses to influenza and coronavirus infections [PDF]

open access: yes, 2006
Both innate and adaptative immune responses contribute to the control of infectious diseases, including by limiting the spreading of zoonotic diseases from animal reservoirs to humans.
Asselin-Paturel   +35 more
core   +2 more sources

Cigarette Smoke Suppresses Type I Interferon-Mediated Antiviral Immunity in Lung Fibroblast and Epithelial Cells [PDF]

open access: yes, 2008
The objective of this study was to investigate the impact of cigarette smoke on innate antiviral defense mechanisms; specifically, we examined the effects of cigarette smoke on the induction of type I interferon (IFN).
Bauer, Carla M.T.   +6 more
core   +2 more sources

Role of Type I and II Interferons in Colorectal Cancer and Melanoma

open access: yesFrontiers in Immunology, 2017
Cancer can be considered an aberrant organ with a hierarchical composition of different cell populations. The tumor microenvironment, including the immune cells and related cytokines, is crucial during all the steps of tumor development.
Simone Di Franco   +4 more
doaj   +1 more source

Evaluation of prognostic value of cell adhesion molecules in chronic hepatitis C therapy

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2010
The most reliable determination of severity and prognosis in chronic viral hepatitis is the histological staging of the disease, which comprises an invasive procedure and is often not well accepted by patients.
N Abdallah   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy